Belen Alvarez Alvarez

Belen Alvarez Alvarez

Auto-generated profile, based on publicly available information

Belen Alvarez Alvarez

Cardiology Department Clinical University Hospital of Santiago de Compostela Santiago de Compostela Spain

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2014 in Open Heart
Verified
Journal Article
Open access
PDF file
BÁBelén Álvarez-Álvarez
Belén Álvarez-Álvarez
SRSergio Raposeiras-Roubín
Sergio Raposeiras-Roubín
EAEmad Abu-Assi
Emad Abu-Assi
CCCristina Cambeiro-González
Cristina Cambeiro-González
SRSantiago Gestal Romani
Santiago Gestal Romani
JGJose R Gonzalez-Juanatey
Jose R Gonzalez-Juanatey
Objectives: The risk of stroke after an acute coronary syndrome (ACS) has increased. The aim of this study was to do a comparative validation of the 6-month GRACE (Global Registry of Acute Coronary Events) risk score and CH2DS2VASc risk score to predict the risk of post-ACS ischaemic stroke. Methods: This was a retrospective study carried out in a single centre with 4229 patients with ACS discharged between 2004 and 2010 (66.9±12.8 years, 27.9% women, 64.2% underwent percutaneous coronary intervention). The primary end point is the occurrence of an ischaemic stroke during follow-up (median 4.6 years, IQR 2.7–7.1 years). Results: 184 (4.4%) patients developed an ischaemic stroke; 153 (83.2%) had sinus rhythm and 31 (16.9%) had atrial fibrillation. Patients with stroke were older, with higher rates of hypertension, diabetes, previous stroke and previous coronary artery disease. The HR for CHA2DS2VASc was 1.36 (95% CI, 1.27 to 1.48, p<0.001) and for GRACE, HR was 1.02(95% CI, 1.01 to 1.03, p<0.001). Both risk scores show adequate discriminative ability (c-index 0.63±0.02 and 0.60±0.02 for CHA2DS2VASc and GRACE, respectively). In the reclassification method there was no difference (Net Reclassification Improvement 1.98%, p=0.69). Comparing moderate-risk/high-risk patients with low-risk patients, both risk scores showed very high negative predictive value (98.5% for CHA2DS2VASc, 98.1% for GRACE). The sensitivity of CHA2DS2VASc score was higher than the GRACE risk score (95.1% vs 87.0%), whereas specificity was lower (14.4% vs 30.2%). Conclusions: The 6-month GRACE model is a clinical risk score that facilitates the identification of individual patients who are at high risk of ischaemic stroke after ACS discharge.

21 March 2021 in Journal of Arrhythmia
Verified
Journal Article
Open access
PDF file
BABelén Alvarez‐Alvarez
Belén Alvarez‐Alvarez
JGJavier García‐Seara
Javier García‐Seara
JMJose L. Martínez‐Sande
Jose L. Martínez‐Sande
MRMoisés Rodríguez-Mañero
Moisés Rodríguez-Mañero
XLXesús A. Fernández López
Xesús A. Fernández López
JGJosé R. González‐Juanatey
José R. González‐Juanatey
Introduction: The benefit of cardiac resynchronization therapy (CRT) in heart failure (HF) patients with reduced left ventricular ejection fraction (LVEF) have been observed in the first year. However, there are few data on long‐term follow‐up and the effect of changes of LVEF on mortality. This study aimed to assess the LV remodeling after CRT implantation and the probable effect of changes in LVEF with repeated measures on mortality over time in a real‐world registry.Methods: Among our cohort of 328 consecutive CRT patients, mixed model effect analysis have been made to describe the temporal evolution of LVEF and LVESV changes over time up with several explanatory variables. Besides, the effect of LVEF along time on the probability of mortality was evaluated using joint modeling for longitudinal and survival data.Results: The study population included 328 patients (253 men; 70.2 ± 9.5 years) in 4.2 (2.9) years follow‐up. There was an increase in LVEF of 11% and a reduction in LVESV of 42 mL during the first year. These changes are more important during the first year, but slight changes remain during the follow‐up. The largest reduction in LVESV occurred in patients with left bundle branch block (LBBB) and the smallest reduction in patients with NYHA IV. The smallest increase in LVEF was an ischemic etiology, longer QRS, and LV electrode in a nonlateral vein. Besides, the results showed that the LVEF profiles taken during follow‐up after CRT were associated with changes in the risk of death.Conclusion: Reverse remodeling of the left ventricle is observed especially during the first year, but it seems to be maintained later after CRT implantation in a contemporary cohort of patients. Longitudinal measurements could give us additional information at predicting the individual mortality risk after adjusting by age and sex compared to a single LVEF measurement after CRT.

1 June 2018 in International Journal of Cardiology
Verified
Journal Article
Closed access
BABelén Alvarez-Alvarez
Belén Alvarez-Alvarez
CCCharigan Abou Jokh Casas
Charigan Abou Jokh Casas
JAJose María Garcia Acuña
Jose María Garcia Acuña
BABelén Cid Alvarez
Belén Cid Alvarez
RBRosa María Agra Bermejo
Rosa María Agra Bermejo
JGJose R Gonzalez-Juanatey
Jose R Gonzalez-Juanatey

1 July 2018 in Indian Pacing and Electrophysiology Journal
Verified
Journal Article
Open access
BABelén Alvarez-Alvarez
Belén Alvarez-Alvarez
JSJavier García- Seara
Javier García- Seara
MRMoisés Rodríguez-Mañero
Moisés Rodríguez-Mañero
DIDiego Iglesias-Alvarez
Diego Iglesias-Alvarez
JMJose L. Martínez-Sande
Jose L. Martínez-Sande
JGJose R Gonzalez-Juanatey
Jose R Gonzalez-Juanatey
Cardiac resynchronization therapy (CRT) is indicated in symptomatic heart failure (HF) patients after achieving optimal medical therapy. However, there are still a large percentage of patients who do not respond to CRT. Malnutrition is a frequent comorbidity in patients with HF, and it is associated with a poorer prognosis. Here, we evaluate the nutritional status of patients assessed by Controlling Nutritional Status (CONUT) score and its association with structural remodeling and cardiovascular events. We investigated the effect of CONUT on HF/death in 302 consecutive patients with a CRT device implanted between 2005 and 2015 in a single tertiary center. We categorized the patients into three groups: normal nutritional status (CONUT 0-1), mild malnutrition (CONUT 2-4) and moderate-severe malnutrition (CONUT ≥ 5). Changes in nutritional status were assessed in patients with mild-to-severe malnutrition prior to CRT. One hundred and forty-eight patients exhibited normal nutritional status (49.0%), 99 patients exhibited mild malnutrition (32.8%) and 55 patients exhibited moderate-severe malnutrition (18.2%). CONUT scores of at least 2 were associated with higher risk of HF/death compared with CONUT 0-1. Significant left ventricular (LV) reverse remodeling was noted in patients with better nutritional status. In addition, those malnutrition patients at baseline that improved nutritional state exhibited fewer HF/death events at follow-up. CONUT score prior to CRT was an independent risk factor of death/HF and was correlated with LV reverse remodeling. Improvements in CONUT score during long-term follow-up were associated with a reduction in the rate of HF/death.

26 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PDPablo Diez-Villanueva
Pablo Diez-Villanueva
JGJose María García-Acuña
Jose María García-Acuña
SRSergio Raposeiras-Roubin
Sergio Raposeiras-Roubin
José BarrabésJosé Barrabés
José Barrabés
Alberto CorderoAlberto Cordero
Alberto Cordero
JSJuan Sanchis
Juan Sanchis
Few studies have addressed to date the interaction between sex and diabetes mellitus (DM) in the prognosis of elderly patients with non-ST-segment elevation acute coronary syndrome (NSTEACS). Our aim was to address the role of DM in the prognosis of non-selected elderly patients with NSTEACS according to sex. A retrospective analysis from 11 Spanish NSTEACS registries was conducted, including patients aged ≥70 years. The primary end point was one-year all-cause mortality. A total of 7211 patients were included, 2,770 (38.4%) were women, and 39.9% had DM. Compared with the men, the women were older (79.95 ± 5.75 vs. 78.45 ± 5.43 years, p < 0.001) and more often had a history of hypertension (77% vs. 83.1%, p < 0.01). Anemia and chronic kidney disease were both more common in women. On the other hand, they less frequently had a prior history of arteriosclerotic cardiovascular disease or comorbidities such as peripheral artery disease and chronic pulmonary disease. Women showed a worse clinical profile on admission, though an invasive approach and in-hospital revascularization were both more often performed in men (p < 0.001). At a one-year follow-up, 1090 patients (15%) had died, without a difference between sexes. Male sex was an independent predictor of mortality (HR = 1.15, 95% CI 1.01 to 1.32, p = 0.035), and there was a significant interaction between sex and DM (p = 0.002). DM was strongly associated with mortality in women (HR: 1.45, 95% CI = 1.18–1.78; p < 0.001), but not in men (HR: 0.98, 95% CI = 0.84–1.14; p = 0.787). In conclusion, DM is associated with mortality in older women with NSTEACS, but not in men.

1 November 2020 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
BÁBelén Álvarez Álvarez
Belén Álvarez Álvarez
CCCharigan Abou Jokh Casas
Charigan Abou Jokh Casas
RBRosa Agra Bermejo
Rosa Agra Bermejo
Alberto CorderoAlberto Cordero
Alberto Cordero
AÁAna Belén Cid Álvarez
Ana Belén Cid Álvarez
JGJosé R. González-Juanatey
José R. González-Juanatey